JP2005046146A5 - - Google Patents

Download PDF

Info

Publication number
JP2005046146A5
JP2005046146A5 JP2004212340A JP2004212340A JP2005046146A5 JP 2005046146 A5 JP2005046146 A5 JP 2005046146A5 JP 2004212340 A JP2004212340 A JP 2004212340A JP 2004212340 A JP2004212340 A JP 2004212340A JP 2005046146 A5 JP2005046146 A5 JP 2005046146A5
Authority
JP
Japan
Prior art keywords
polypeptide
nucleic acid
cell
antibody
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004212340A
Other languages
English (en)
Japanese (ja)
Other versions
JP3803681B2 (ja
JP2005046146A (ja
Filing date
Publication date
Priority claimed from PCT/US1998/025108 external-priority patent/WO1999028462A2/en
Priority claimed from PCT/US1999/005028 external-priority patent/WO1999046281A2/en
Priority claimed from PCT/US1999/012252 external-priority patent/WO1999063088A2/en
Priority claimed from PCT/US1999/020111 external-priority patent/WO2000012708A2/en
Priority claimed from PCT/US1999/020594 external-priority patent/WO2000015666A2/en
Priority claimed from PCT/US1999/020944 external-priority patent/WO2000015792A2/en
Priority claimed from PCT/US1999/021090 external-priority patent/WO2000015796A2/en
Priority claimed from PCT/US1999/021547 external-priority patent/WO2000015797A2/en
Priority claimed from PCT/US1999/023089 external-priority patent/WO2000021996A2/en
Application filed filed Critical
Publication of JP2005046146A publication Critical patent/JP2005046146A/ja
Publication of JP2005046146A5 publication Critical patent/JP2005046146A5/ja
Publication of JP3803681B2 publication Critical patent/JP3803681B2/ja
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004212340A 1998-12-01 2004-07-20 血管形成及び心臓血管新生の促進又は阻害 Expired - Lifetime JP3803681B2 (ja)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
PCT/US1998/025108 WO1999028462A2 (en) 1997-12-03 1998-12-01 Polypeptides and nucleic acids encoding the same
US11285098P 1998-12-16 1998-12-16
US11555499P 1999-01-12 1999-01-12
PCT/US1999/005028 WO1999046281A2 (en) 1998-03-10 1999-03-08 Novel polypeptides and nucleic acids encoding the same
US12395799P 1999-03-12 1999-03-12
US13144599P 1999-04-28 1999-04-28
US13428799P 1999-05-14 1999-05-14
PCT/US1999/012252 WO1999063088A2 (en) 1998-06-02 1999-06-02 Membrane-bound proteins and nucleic acids encoding the same
US14103799P 1999-06-23 1999-06-23
US14475899P 1999-07-20 1999-07-20
US14569899P 1999-07-26 1999-07-26
PCT/US1999/020111 WO2000012708A2 (en) 1998-09-01 1999-09-01 Further pro polypeptides and sequences thereof
PCT/US1999/020594 WO2000015666A2 (en) 1998-09-10 1999-09-08 Compositions and methods for the treatment of tumors
PCT/US1999/020944 WO2000015792A2 (en) 1998-09-14 1999-09-13 Promotion or inhibition of angiogenesis and cardiovascularization
PCT/US1999/021547 WO2000015797A2 (en) 1998-09-17 1999-09-15 Compositions and methods for the treatment of immune related diseases
PCT/US1999/021090 WO2000015796A2 (en) 1998-09-16 1999-09-15 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US1999/023089 WO2000021996A2 (en) 1998-10-13 1999-10-05 Methods and compositions for inhibiting neoplastic cell growth
US16250699P 1999-10-29 1999-10-29

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000584912A Division JP3695642B2 (ja) 1998-12-01 1999-11-30 血管形成及び心臓血管新生の促進又は阻害

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2005180188A Division JP4358159B2 (ja) 1998-12-01 2005-06-21 血管形成及び心臓血管新生の促進又は阻害

Publications (3)

Publication Number Publication Date
JP2005046146A JP2005046146A (ja) 2005-02-24
JP2005046146A5 true JP2005046146A5 (enExample) 2005-09-22
JP3803681B2 JP3803681B2 (ja) 2006-08-02

Family

ID=37398593

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000584912A Expired - Fee Related JP3695642B2 (ja) 1998-12-01 1999-11-30 血管形成及び心臓血管新生の促進又は阻害
JP2004212340A Expired - Lifetime JP3803681B2 (ja) 1998-12-01 2004-07-20 血管形成及び心臓血管新生の促進又は阻害
JP2005180188A Expired - Lifetime JP4358159B2 (ja) 1998-12-01 2005-06-21 血管形成及び心臓血管新生の促進又は阻害

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2000584912A Expired - Fee Related JP3695642B2 (ja) 1998-12-01 1999-11-30 血管形成及び心臓血管新生の促進又は阻害

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2005180188A Expired - Lifetime JP4358159B2 (ja) 1998-12-01 2005-06-21 血管形成及び心臓血管新生の促進又は阻害

Country Status (9)

Country Link
EP (1) EP1135485B1 (enExample)
JP (3) JP3695642B2 (enExample)
KR (1) KR100529270B1 (enExample)
AT (1) ATE458050T1 (enExample)
AU (1) AU771751C (enExample)
CA (1) CA2347835A1 (enExample)
IL (1) IL202176A0 (enExample)
MX (1) MXPA01005169A (enExample)
WO (1) WO2000032221A2 (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053760A2 (en) * 1999-03-12 2000-09-14 Genentech, Inc. Method of preventing the death of retinal neurons and treating ocular diseases
WO2002008284A2 (en) * 2000-07-20 2002-01-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
WO2001005972A1 (en) * 1999-07-20 2001-01-25 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US7285267B2 (en) 1997-01-14 2007-10-23 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6α & 6β
ES2286843T3 (es) 1997-01-14 2007-12-01 Human Genome Sciences, Inc. Receptores 6 alfa y 6 beta del factor de necrosis tumoral.
US6930170B2 (en) * 1997-06-16 2005-08-16 Genentech, Inc. PRO1184 polypeptides
ATE393222T1 (de) 1997-09-18 2008-05-15 Genentech Inc Dcr3 polypeptid, ein tnfr homolog
US6503184B1 (en) 1997-10-21 2003-01-07 Human Genome Sciences, Inc. Human tumor necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2
US6689607B2 (en) 1997-10-21 2004-02-10 Human Genome Sciences, Inc. Human tumor, necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2
PT2016951E (pt) 1998-03-17 2012-09-27 Genentech Inc Polipéptidos homólogos de vegf e de bmp1
US6949339B1 (en) 1998-05-21 2005-09-27 Diadexus, Inc. Method of diagnosing, monitoring, and staging colon cancer
JP2002518010A (ja) 1998-06-16 2002-06-25 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ９４個のヒト分泌タンパク質
US7014996B1 (en) 1998-10-02 2006-03-21 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
EP1131430B1 (en) 1998-11-10 2007-01-17 Emory University Mitogenic regulators
US6432673B1 (en) 1998-12-07 2002-08-13 Zymogenetics, Inc. Growth factor homolog ZVEGF3
US6756219B1 (en) * 1998-12-09 2004-06-29 Shionogi & Co., Ltd. Human secretory type phospholipase a2
AU2486300A (en) * 1998-12-30 2000-07-31 Millennium Pharmaceuticals, Inc. Secreted proteins and nucleic acids encoding them
KR20010104373A (ko) * 1999-03-08 2001-11-24 제넨테크, 인크. 혈관신생 및 심혈관형성의 촉진 또는 억제 방법
EP1159431A2 (en) * 1999-03-11 2001-12-05 Mount Sinai Hospital Human kallikrein-like genes
CA2378179A1 (en) * 1999-07-12 2001-01-18 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
AU3902600A (en) * 1999-09-15 2001-04-17 Genentech Inc. Compositions and methods for the treatment of immune related diseases
CN1433482A (zh) * 1999-12-09 2003-07-30 三共株式会社 高脂血症的治疗或预防剂的检验方法
US7119165B2 (en) 2000-01-12 2006-10-10 Yale University Nogo receptor-mediated blockade of axonal growth
ES2341842T3 (es) * 2000-01-12 2010-06-29 Yale University Bloqueo del crecimiento axonal mediado por el receptor de nogo.
US7135303B2 (en) 2000-02-28 2006-11-14 The United States Of America As Represented By The Department Of Health And Human Services Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
AU4880901A (en) * 2000-04-21 2001-11-07 Takeda Chemical Industries Ltd Novel insulin/igf/relaxin family polypeptides and dnas thereof
ES2341608T3 (es) 2000-10-06 2010-06-23 Yale University Homologos del receptor de nogo.
US20020111302A1 (en) * 2000-11-30 2002-08-15 Y. Tom Tang Novel nucleic acids and polypeptides
JPWO2002057448A1 (ja) * 2000-12-27 2004-05-20 第一ファインケミカル株式会社 新規ペプチド及びその活性
EP2280030A3 (en) 2001-04-10 2011-06-15 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
WO2003006687A2 (en) * 2001-07-10 2003-01-23 Medigene Ag Novel target genes for diseases of the heart
CA2470900A1 (en) * 2001-12-19 2003-07-03 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
AU2003225623A1 (en) * 2002-03-01 2003-09-16 Blood Center Research Foundation Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells
AU2003220805A1 (en) * 2002-03-28 2003-10-13 Yamanouchi Pharmaceutical Co., Ltd. Antiopoietin-related growth factor
AU2003246085A1 (en) * 2002-06-28 2004-01-19 Takeda Chemical Industries, Ltd. Diagnostics/preventives/remedies for respiratory diseases
CA2495121A1 (en) 2002-08-10 2004-02-19 Yale University Nogo receptor antagonists
WO2005068497A1 (en) * 2004-01-06 2005-07-28 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Iis: a novel ifn-gamma-inducible protein, member of the secretoglobin family, that modulates cellular invasion and migration
EP1904091A4 (en) 2005-07-07 2009-12-23 Univ Yale COMPOSITIONS AND METHODS FOR SUPPRESSING THE INHIBITION OF AXON GROWTH
JP6449338B2 (ja) 2014-06-06 2019-01-09 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ グルココルチコイド誘導腫瘍壊死因子受容体（ｇｉｔｒ）に対する抗体およびその使用
JP6812364B2 (ja) 2015-06-03 2021-01-13 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 癌診断用抗ｇｉｔｒ抗体
CN108738324B (zh) 2015-11-19 2022-06-21 百时美施贵宝公司 抗糖皮质激素诱导的肿瘤坏死因子受体(gitr)抗体及其用途
KR20200006115A (ko) 2017-05-16 2020-01-17 브리스톨-마이어스 스큅 컴퍼니 항-gitr 효능제 항체에 의한 암의 치료
CN109136275B (zh) * 2017-06-19 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化gitr基因改造动物模型的制备方法及应用
CN114507677B (zh) * 2022-02-16 2023-09-05 中国人民解放军空军军医大学 Ndufs1基因在治疗心梗后心衰中的应用和相关产品
EP4484444A1 (en) * 2023-06-28 2025-01-01 Centre National de la Recherche Scientifique Protein and fragments thereof, and their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900673A (en) * 1988-03-28 1990-02-13 President And Fellows Of Harvard College Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression
CA2134773A1 (en) 1992-06-04 1993-12-09 Robert J. Debs Methods and compositions for in vivo gene therapy
AU692865B2 (en) * 1994-04-26 1998-06-18 Children's Medical Center Corporation Angiostatin and method of use for inhibition of angiogenesis
US5681746A (en) 1994-12-30 1997-10-28 Chiron Viagene, Inc. Retroviral delivery of full length factor VIII
US6337387B1 (en) * 1995-11-17 2002-01-08 Asahi Kasei Kabushiki Kaisha Differentiation-suppressive polypeptide

Similar Documents

Publication Publication Date Title
JP2005046146A5 (enExample)
JP2006068016A5 (enExample)
JP2006081548A5 (enExample)
JP2008301822A5 (enExample)
CA2479476A1 (en) Compositions and methods for the treatment of tumor
JP2010162016A5 (enExample)
JP2006223304A5 (enExample)
JP2002516103A5 (enExample)
JP2008278887A5 (enExample)
JP2001511347A5 (enExample)
CN109678958B (zh) 一种人NT-proBNP特异性重组羊单克隆抗体及其制备方法和应用
CA2503125A1 (en) Novel composition and methods for the treatment of immune related diseases
JP2004041218A5 (enExample)
JP2005518212A5 (enExample)
WO2010052344A2 (en) Antibodies to modified human igf-1/e peptides
JP2003527844A5 (enExample)
JP2003531634A5 (enExample)
JP2006521810A5 (enExample)
JP2006518582A5 (enExample)
JP2013510574A (ja) チャイニーズハムスターからのグリコシルトランスフェラーゼおよび関連方法
JP2013502217A5 (enExample)
KR102603693B1 (ko) 소수성 테일 도메인이 제거된 먹장어 유래 vlrb 단백질에 폴돈 도메인이 연결된 융합 단백질 및 이의 용도
JP2004500055A5 (enExample)
JP4892717B2 (ja) ニワトリキメラ抗体およびその利用
KR101972894B1 (ko) 소수성 테일 도메인이 제거된 먹장어 유래 vlrb 단백질에 칠성장어 유래 vlrb 단백질의 c 말단 서열이 연결된 융합 단백질 및 이의 용도